• NUTRYELT is used as part of an intravenous nutrition regimen, to cover basal or moderately increased trace element requirements in parenteral nutrition.
• NUTRYELT is indicated for adults only.
• Gastrointestinal disorders (e.g., short bowel syndrome, Crohn’s disease)
• Post-operative recovery when oral intake is not feasible
• Cancer patients undergoing chemotherapy or radiation therapy, with disrupted digestive function
• Neurological conditions where oral or enteral feeding is not possible
• Burns, trauma, or sepsis requiring nutritional support

* রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Each 10 ml vial contains-

• Ferrous gluconate: Iron (Fe): 1 mg
• Zinc gluconate: Zinc (Zn): 10 mg
• Copper gluconate: Copper (Cu): 0.30 mg
• Manganese gluconate: Manganese (Mn): 0.055 mg
• Sodium fluoride: Fluorine (F): 0.95 mg
• Cobalt (Co): 0.30 mg
• Potassium iodide: Iodine (I): 130 µg
• Sodium selenite: Selenium (Se): 70 µg
• Sodium molybdate: Molybdenum (Mo): 20 µg
• Chromic chloride: Chromium (Cr): 10 µg

A balanced parenteral nutrition (PN) multi-trace element solution containing nine essential trace elements that helps avoid micronutrient deficiencies and aligns with international guidelines. NUTRYELT is a parenteral nutrition solution, meaning it provides essential nutrients directly into the bloodstream, bypassing the gastrointestinal system. The nutrients in NUTRYELT are metabolized by the body to provide:

• Energy through glucose.
• Protein synthesis and tissue repair via amino acids.
• Cellular structure and function via lipids and fatty acids.
• Metabolic regulation and maintenance of physiological functions through vitamins, minerals, and electrolytes.

NUTRYELT supports vital physiological processes such as immune function, cellular repair, and the generation of energy from stored nutrients.

Patients with baseline or moderately increased requirements: 1 ampoule (10 ml) of NUTRYELT/day

Patients with significantly increased TE requirements: 2 ampoules (20 ml) of NUTRYELT/day

Diluted in an infusion solution of 250 ml 0.9% NaCl or 250 ml 5 % of glucose or added to PN mixtures

After dilution, the physico chemical stability of the diluted solution has been demonstrated for 48 hours at 25°C protected from light.

Drug interactions: Parenteral nutrition may interact with certain medications, particularly those that affect the metabolism of nutrients (e.g., insulin for glucose control, diuretics for electrolyte balance).

Electrolyte imbalances: Medications that impact kidney or liver function may also affect electrolyte balance, which can be managed with careful monitoring.

• Children or patients <40kg
• Severe cholestasis (bilirubin levels>140 µmol/l)
• Hypersensitivity to one of the active substances or to the excipient
• Wilson's diseases
• Hemochromatosis
• Elevated serum concentrations of any of the NUTRYELT constituents

Hyperglycemia (high blood sugar) due to the glucose content.
Electrolyte imbalances: Changes in sodium, potassium, or calcium levels.
Infections: Due to the intravenous administration route.
Liver dysfunction or fatty liver, particularly with prolonged use.
Thrombophlebitis (inflammation of veins) at the injection site.
Gastrointestinal issues: If transitioning back to enteral feeding, nausea or diarrhea may occur

Parenteral nutrition should be used cautiously during pregnancy. The benefits and risks need to be carefully evaluated, as malnutrition and electrolyte disturbances in the mother could affect fetal development. If necessary, it should be administered under medical supervision.

Monitoring required: Regular monitoring of blood glucose, electrolytes, and liver function is essential.

Infection risk: Since the solution is administered intravenously, aseptic techniques must be followed rigorously to avoid infections.

Fluid overload: Caution should be exercised in patients with compromised renal function or heart failure.

Parenteral nutritional preparations

Protected from light, temperature below 25°C.